328
Views
0
CrossRef citations to date
0
Altmetric
Review

Comparison of the efficacy and safety of rapid-acting insulin analogs, lispro versus aspart, in the treatment of diabetes: a systematic review of randomized controlled trials

, , , , , & show all
Pages 543-561 | Received 24 Jan 2024, Accepted 18 Jun 2024, Published online: 28 Jun 2024